OSI-906 + Placebo
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 27/100
27
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Advanced Hepatocellular Carcinoma (HCC)
Conditions
Advanced Hepatocellular Carcinoma (HCC)
Trial Timeline
Jan 10, 2011 → Dec 28, 2011
NCT ID
NCT01101906About OSI-906 + Placebo
OSI-906 + Placebo is a phase 2 stage product being developed by Astellas Pharma for Advanced Hepatocellular Carcinoma (HCC). The current trial status is terminated. This product is registered under clinical trial identifier NCT01101906. Target conditions include Advanced Hepatocellular Carcinoma (HCC).
What happened to similar drugs?
16 of 20 similar drugs in Advanced Hepatocellular Carcinoma (HCC) were approved
Approved (16) Terminated (1) Active (4)
Hype Score Breakdown
Clinical
12
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01101906 | Phase 2 | Terminated |
Competing Products
20 competing products in Advanced Hepatocellular Carcinoma (HCC)